Ratings by Dawson James (Jason Kolbert)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2024 | Know Labs | KNW | Downgrade | Neutral (Buy) |
0.90 (2.14) |
137.78% | Details | |
| 2/20/2024 | Know Labs | KNW | Downgrade | Neutral (Buy) |
0.49 (2.14) |
336.73% | Details | |
| 12/28/2023 | CytoSorbents | CTSO | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2023 | Zomedica | ZOM | Downgrade | Neutral (Buy) |
0.18 (0.10) |
-44.44% | Details | |
| 11/13/2023 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2023 | Arch Therapeutics | ARTH | Downgrade | Neutral (Buy) |
0.60 (0.16) |
-73.33% | Details | |
| 10/10/2023 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2023 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2023 | Genprex | GNPX | Downgrade | Neutral (Buy) |
0.45 (1.95) |
333.33% | Details | |
| 8/3/2023 | Bluejay Diagnostics | BJDX | Downgrade | Neutral (Buy) |
5.46 (1.86) |
-65.93% | Details | |
| 7/17/2023 | Hillstream BioPharma | HILS | Downgrade | Neutral (Buy) |
0.38 (0.23) |
-39.47% | Details | |
| 5/4/2023 | Citius Pharmaceuticals | CTXR | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2023 | Zomedica | ZOM | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2023 | NRx Pharmaceuticals, Inc. | NRXP | New Coverage | Buy (N/A) |
0.69 (1.70) |
146.38% | Details | |
| 3/6/2023 | Arch Therapeutics | ARTH | Downgrade | Neutral (Buy) |
4.15 (0.16) |
-96.14% | Details | |
| 3/3/2023 | GeoVax Labs Inc. | GOVX | New Coverage | Buy (N/A) |
0.72 (1.79) |
148.61% | Details | |
| 2/22/2023 | Hillstream BioPharma | HILS | New Coverage | Buy (N/A) |
1.24 (0.23) |
-81.45% | Details | |
| 2/13/2023 | Sorrento Therapeutics | SRNE | Downgrade | Neutral (Buy) |
0.94 (0.00) |
-100% | Details | |
| 2/6/2023 | Cemtrex | CETX | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Zomedica | ZOM | New Coverage | Buy (N/A) |
0.19 (0.10) |
-47.37% | Details | |
| 12/28/2022 | Can-Fite BioPharma | CANF | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2022 | Smart for Life | SMFL | Downgrade | Neutral (Buy) |
0.26 (0.78) |
200% | Details | |
| 11/11/2022 | BioCardiAa | BCDA | Downgrade | Neutral (Buy) |
1.92 (1.18) |
-38.54% | Details | |
| 9/16/2022 | ADiTx Therapeutics Inc. | ADTX | Downgrade | Neutral (Buy) |
10.39 (0.47) |
-95.48% | Details | |
| 8/29/2022 | Smart for Life | SMFL | New Coverage | Buy (N/A) |
0.53 (0.78) |
47.17% | Details | |
| 8/19/2022 | Sorrento Therapeutics | SRNE | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2022 | ADiTx Therapeutics Inc. | ADTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Mesoblast Limited | MESO | Downgrade | Neutral (Buy) |
3.49 (15.85) |
354.15% | Details | |
| 7/19/2022 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2022 | Dyadic International | DYAI | Downgrade | Neutral (Buy) |
3.14 (0.77) |
-75.48% | Details | |
| 7/13/2022 | Pluristem Therapeutics | PSTI | Downgrade | Neutral (Buy) |
1.19 (1.00) |
-15.97% | Details | |
| 7/11/2022 | Can-Fite BioPharma | CANF | Maintain | Buy (Buy) |
|
Details | ||
| 6/29/2022 | Can-Fite BioPharma | CANF | Maintain | Buy (Buy) |
|
Details | ||
| 5/25/2022 | Citius Pharmaceuticals | CTXR | Maintain | Buy (Buy) |
|
Details | ||
| 5/25/2022 | Brainstorm Cell Therapeutics | BCLI | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/19/2022 | Adamis Pharmaceuticals | ADMP | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/19/2022 | Adamis Pharmaceuticals | ADMP | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/4/2022 | CytoSorbents | CTSO | Maintain | Buy (Buy) |
|
Details | ||
| 5/3/2022 | Lineage Cell Therapeutics Inc. | LCTX | Maintain | Buy (Buy) |
|
Details | ||
| 4/29/2022 | Mesoblast Limited | MESO | Maintain | Buy (Buy) |
|
Details | ||
| 4/26/2022 | Citius Pharmaceuticals | CTXR | Maintain | Buy (Buy) |
|
Details | ||
| 4/21/2022 | Bluejay Diagnostics | BJDX | Maintain | Buy (Buy) |
|
Details | ||
| 4/20/2022 | Dare Bioscience | DARE | Maintain | Buy (Buy) |
|
Details | ||
| 4/18/2022 | Citius Pharmaceuticals | CTXR | Maintain | Buy (Buy) |
|
Details | ||
| 4/5/2022 | ADiTx Therapeutics Inc. | ADTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/30/2022 | BioCardiAa | BCDA | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2022 | Fortress Biotech | FBIO | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2022 | Collplant Holdings Inc. | CLGN | Maintain | Buy (Buy) |
|
Details | ||
| 3/23/2022 | Caladrius Biosciences | CLBS | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/22/2022 | Adamis Pharmaceuticals | ADMP | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/21/2022 | Dyadic International | DYAI | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2022 | OncoSec Medical | ONCS | Maintain | Buy (Buy) |
|
Details | ||
| 3/14/2022 | Sorrento Therapeutics | SRNE | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2022 | Lineage Cell Therapeutics Inc. | LCTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/10/2022 | Bluejay Diagnostics | BJDX | Maintain | Buy (Buy) |
|
Details | ||
| 3/9/2022 | CytoSorbents | CTSO | Maintain | Buy (Buy) |
|
Details | ||
| 3/8/2022 | Can-Fite BioPharma | CANF | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2022 | BioCardiAa | BCDA | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Check-Cap | CHEK | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | IsoRay, Inc. | ISR | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/1/2022 | First Wave BioPharma, Inc. | FWBI | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/28/2022 | Dare Bioscience | DARE | Maintain | Buy (Buy) |
|
Details | ||
| 2/23/2022 | Celsion Corp | CLSN | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/15/2022 | Citius Pharmaceuticals | CTXR | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2022 | Anavex Life Sciences | AVXL | Maintain | Buy (Buy) |
|
Details | ||
| 2/8/2022 | Know Labs | KNWN | New Coverage | Buy (N/A) |
1.59 (0.08) |
-94.97% | Details | |
| 2/7/2022 | Check-Cap | CHEK | Upgrade | Buy (Neutral) |
0.60 (1.61) |
168.33% | Details | |
| 1/31/2022 | Safe-T Group | SFET | New Coverage | Buy (N/A) |
0.58 (2.86) |
393.1% | Details | |
| 1/26/2022 | BioCardiAa | BCDA | Upgrade | Buy (Neutral) |
1.42 (1.18) |
-16.9% | Details | |
| 1/12/2022 | Bluejay Diagnostics | BJDX | New Coverage | Buy (N/A) |
2.74 (1.86) |
-32.12% | Details | |
| 1/4/2022 | Sorrento Therapeutics | SRNE | Maintain | Buy (Buy) |
|
Details | ||
| 12/20/2021 | Can-Fite BioPharma | CANF | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2021 | ADiTx Therapeutics Inc. | ADTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2021 | Citius Pharmaceuticals | CTXR | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2021 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2021 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2021 | Arch Therapeutics | ARTH | New Coverage | Buy (N/A) |
0.13 (0.16) |
23.08% | Details | |
| 4/16/2021 | BioCardiAa | BCDA | Downgrade | Neutral (Buy) |
4.12 (1.18) |
-71.36% | Details | |
| 4/7/2021 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2021 | Check-Cap | CHEK | Downgrade | Neutral (Buy) |
2.39 (0.60) |
-74.9% | Details | |
| 3/2/2021 | BioCardiAa | BCDA | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2021 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2021 | Citius Pharmaceuticals | CTXR | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2021 | AzurRx Biopharma | AZRX | Downgrade | Neutral (Buy) |
0.85 (3.45) |
305.88% | Details | |
| 10/20/2020 | IsoRay, Inc. | ISR | Downgrade | Neutral (Buy) |
0.57 (0.38) |
-33.33% | Details | |
| 8/24/2020 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Sigma Labs | SGLB | New Coverage | Buy (N/A) |
2.41 (1.05) |
-56.43% | Details | |
| 7/28/2020 | Soligenix | SNGX | Downgrade | Neutral (Buy) |
2.13 (1.19) |
-44.13% | Details | |
| 7/27/2020 | OncoSec Medical | ONCS | New Coverage | Buy (N/A) |
3.19 (0.28) |
-91.22% | Details | |
| 7/20/2020 | Sorrento Therapeutics | SRNE | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2020 | Celsion Corp | CLSN | Downgrade | Neutral (Buy) |
1.29 (1.96) |
51.94% | Details | |
| 7/13/2020 | Celsion Corp | CLSN | Downgrade | Neutral (Buy) |
3.58 (1.96) |
-45.25% | Details | |
| 6/25/2020 | Celsion Corp | CLSN | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2020 | Adamis Pharmaceuticals | ADMP | Upgrade | Buy (Neutral) |
0.59 (0.78) |
32.2% | Details | |
| 6/2/2020 | Sorrento Therapeutics | SRNE | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2020 | Sorrento Therapeutics | SRNE | New Coverage | Buy (N/A) |
5.07 (0.00) |
-100% | Details | |
| 5/18/2020 | Caladrius Biosciences | CLBS | Downgrade | Neutral (Buy) |
1.83 (0.43) |
-76.5% | Details | |
| 3/31/2020 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2020 | CytoSorbents | CTSO | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Adamis Pharmaceuticals | ADMP | Downgrade | Neutral (Buy) |
0.55 (0.59) |
7.27% | Details | |
| 2/13/2020 | IsoRay, Inc. | ISR | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2020 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2020 | Collplant Holdings Inc. | CLGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2020 | IMAC, Holdings Inc. | IMAC | Downgrade | Neutral (Buy) |
1.44 (1.01) |
-29.86% | Details | |
| 1/13/2020 | IMAC, Holdings Inc. | IMAC | Downgrade | Neutral (Buy) |
1.59 (1.44) |
-9.43% | Details | |
| 12/19/2019 | Mesoblast Limited | MESO | New Coverage | Buy (N/A) |
6.75 (15.85) |
134.81% | Details | |
| 12/16/2019 | Pluristem Therapeutics | PSTI | New Coverage | Buy (N/A) |
3.41 (1.00) |
-70.67% | Details | |
| 12/5/2019 | Check-Cap | CHEK | New Coverage | Buy (N/A) |
1.36 (2.39) |
75.74% | Details | |
| 11/26/2019 | Adamis Pharmaceuticals | ADMP | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2019 | Collplant Holdings Inc. | CLGN | New Coverage | Buy (N/A) |
4.67 (0.61) |
-86.94% | Details | |
| 10/17/2019 | Dyadic International | DYAI | New Coverage | Neutral () |
6.66 (0.77) |
-88.44% | Details | |
| 10/15/2019 | Dyadic International | DYAI | New Coverage | Buy (N/A) |
6.39 (6.66) |
4.23% | Details | |
| 9/24/2019 | MYnd Analytics | MYND | Downgrade | Neutral (Buy) |
1.17 (0.43) |
-63.25% | Details | |
| 9/17/2019 | BioCardiAa | BCDA | New Coverage | Buy (N/A) |
5.05 (1.18) |
-76.63% | Details | |
| 9/6/2019 | Citius Pharmaceuticals | CTXR | New Coverage | Buy (N/A) |
1.19 (0.84) |
-29.41% | Details | |
| 8/26/2019 | Fortress Biotech | FBIO | New Coverage | Buy (N/A) |
1.58 (3.34) |
111.39% | Details | |
| 8/26/2019 | Athersys | ATHX | New Coverage | Buy (N/A) |
1.27 (0.10) |
-92.13% | Details | |
| 8/12/2019 | ADMA Biologics | ADMA | Downgrade | Neutral (Buy) |
3.48 (15.39) |
342.24% | Details | |
| 8/5/2019 | Soligenix | SNGX | New Coverage | Buy (N/A) |
1.23 (2.13) |
73.17% | Details | |
| 8/5/2019 | IMAC, Holdings Inc. | IMAC | New Coverage | Buy (N/A) |
3.50 (1.59) |
-54.57% | Details | |
| 8/5/2019 | Celsion Corp | CLSN | New Coverage | Buy (N/A) |
1.71 (3.58) |
109.36% | Details | |
| 7/24/2019 | Anavex Life Sciences | AVXL | New Coverage | Buy (N/A) |
2.57 (4.65) |
80.93% | Details | |
| 7/2/2019 | Adamis Pharmaceuticals | ADMP | New Coverage | Buy (N/A) |
1.30 (0.78) |
-40% | Details | |
| 7/1/2019 | IsoRay, Inc. | ISR | New Coverage | Buy (N/A) |
0.42 (0.57) |
35.71% | Details | |
| 4/12/2019 | MYnd Analytics | MYND | New Coverage | Buy (N/A) |
1.32 (1.17) |
-11.36% | Details | |
| 2/27/2019 | Caladrius Biosciences | CLBS | New Coverage | Buy (N/A) |
4.20 (1.83) |
-56.43% | Details | |
| 1/3/2019 | Jaguar Animal Health | JAGX | New Coverage | Buy (N/A) |
0.27 (0.59) |
118.52% | Details | |
| 12/18/2018 | Brainstorm Cell Therapeutics | BCLI | New Coverage | Buy (N/A) |
3.05 (1.17) |
-61.64% | Details |
